E1	Condition:T1 
E3	Condition:T3 
E5	Observation:T5 Name:T6 Minimum-Count:E39
E9	Procedure:T9 Name:T10
E11	Condition:T11 
E15	Procedure:T15 Name:T16
E16	Eq-Comparison:T30 Temporal-Period:T31
E17	Eq-Comparison:T32 Temporal-Period:T33
E18	Eq-Comparison:T34 Temporal-Period:T35
E19	Eq-Comparison:T36 Temporal-Period:T37
E20	Eq-Comparison:T38 Operator:T19 Value:T39 Temporal-Unit:T21
E2	Condition:T22 Name:T40
E4	Modifier:T41 Modifies:T40
E6	Condition:T42 Name:T43
E8	Condition:T44 Name:T45
E10	Procedure:T46 Name:T47
E14	Condition:T49 Name:T50
E21	Modifier:T51 Modifies:T50
E22	Modifier:T52 Modifies:T50
E24	Condition:T54 Name:T55
E25	Condition:T23 Name:T56
E26	Condition:T57 Name:T58
E27	Modifier:T59 Modifies:T58
E28	Procedure:T60 Name:T61
E30	Condition:T63 Name:T64
E31	Modifier:T24 Modifies:E1
E32	Modifier:T65 Modifies:E1
E34	Modifier:T25 Modifies:E3
E35	Modifier:T67 Modifies:E3
E37	Condition:T69 Name:T70
E39	Eq-Comparison:T26 Operator:T72 Value:T73
E7	Procedure:T7 Name:T8 Temporality:E17
E40	Procedure:T74 
E41	Assertion:T75 Asserted:E40
E42	Observation:T27 Name:T76
E43	Procedure:T77 Name:T78
E44	Modifier:T79 Modifies:T78
E45	Assertion:T80 Asserted:E43
E46	Procedure:T81 Name:T82
E47	Risk:T83 
E48	Exception:T84 From:E43 Except:E46
E49	Eq-Comparison:T85 Operator:T86 Temporal-Unit:T20 Value:T28
E50	Procedure:T87 Name:T88 Temporality:E18
E51	Study:T89 Study-Of:E52
E52	Drug:T90 Name:T91 Temporality:E53 Temporality2:E49
E53	Eq-Comparison:T92 Temporal-Recency:T93
E55	Observation:T17 Name:T95 Numeric-Filter:E56
E56	Eq-Comparison:T96 Unit:T97 Operator:T98 Operator2:T18 Value:T29
E57	Study:T99 
E59	Procedure:T101 Temporality:E19
E60	Drug:T102 Name:T103
E61	Drug:T104 Name:T105
E13	Immunization:T13 Name:T14
E62	Exception:T106 From:E61 Except:E13
E63	Modifier:T107 Modifies:T10
E64	Modifier:T108 Modifies:T10
E66	Condition:T110 
E67	Condition:T111 Name:T112
E69	Condition:T114 Name:T115
E70	Condition:T116 Name:T117
E72	Assertion:T119 Asserted:E69 Asserted2:E70
E73	Condition:T120 Name:T121 Temporality:E16
E74	Other:T122 Is-Other:E73
E75	Procedure:T123 Temporality:E20
E76	Modifier:T124 Modifies:E75
E77	Assertion:T125 Asserted:E75
E78	Study:T126 
T1	Condition 485 492	disease
T3	Condition 533 540	disease
T5	Observation 594 600	lesion
T6	Observation-Name 594 600	lesion
T9	Procedure 1348 1363	transplantation
T10	Procedure-Name 1348 1363	transplantation
T11	Condition 638 657	disease progression
T15	Procedure 1042 1054	radiotherapy
T16	Procedure-Name 1042 1054	radiotherapy
T18	Eq-Operator 1167 1169	<=
T19	Eq-Operator 1508 1510	<=
T20	Eq-Temporal-Unit 990 995	weeks
T21	Eq-Temporal-Unit 1513 1519	months
T28	Eq-Value 988 989	2
T29	Eq-Value 1171 1172	1
T30	Eq-Comparison 1461 1467	active
T31	Eq-Temporal-Period 1461 1467	active
T32	Eq-Comparison 661 666	prior
T33	Eq-Temporal-Period 661 666	prior
T34	Eq-Comparison 1004 1009	prior
T35	Eq-Temporal-Period 1004 1009	prior
T36	Eq-Comparison 1190 1195	Prior
T37	Eq-Temporal-Period 1190 1195	Prior
T38	Eq-Comparison 1508 1519	<=12 months
T22	Condition 76 91	prostate cancer
T40	Condition-Name 76 91	prostate cancer
T41	Modifier 44 75	Metastatic castration-resistant
T42	Condition 93 98	mCRPC
T43	Condition-Name 93 98	mCRPC
T44	Condition 132 146	adenocarcinoma
T45	Condition-Name 132 146	adenocarcinoma
T46	Procedure 105 115	histologic
T47	Procedure-Name 105 115	histologic
T49	Condition 148 162	Adenocarcinoma
T50	Condition-Name 148 162	Adenocarcinoma
T51	Modifier 168 178	small-cell
T52	Modifier 182 196	neuroendocrine
T54	Condition 218 223	mCRPC
T55	Condition-Name 218 223	mCRPC
T23	Condition 295 300	mCRPC
T56	Condition-Name 295 300	mCRPC
T57	Condition 368 377	carcinoma
T58	Condition-Name 368 377	carcinoma
T59	Modifier 346 367	metastatic renal cell
T60	Procedure 321 335	pathologically
T61	Procedure-Name 321 335	pathologically
T63	Condition 379 382	RCC
T64	Condition-Name 379 382	RCC
T24	Modifier 475 484	evaluable
T65	Modifier 461 471	Measurable
T25	Modifier 523 532	evaluable
T67	Modifier 509 519	measurable
T69	Condition 545 560	prostate cancer
T70	Condition-Name 545 560	prostate cancer
T26	Eq-Comparison 570 582	At least one
T72	Eq-Operator 570 578	At least
T73	Eq-Value 579 582	one
T7	Procedure 667 674	therapy
T8	Procedure-Name 667 674	therapy
T74	Procedure 703 712	treatment
T75	Assertion 680 688	requires
T27	Observation 747 754	lesions
T76	Observation-Name 747 754	lesions
T77	Procedure 889 897	biopsies
T78	Procedure-Name 889 897	biopsies
T79	Modifier 877 888	fresh tumor
T80	Assertion 846 854	agree to
T81	Procedure 924 930	biopsy
T82	Procedure-Name 924 930	biopsy
T83	Risk 949 953	risk
T84	Exception 899 905	unless
T85	Eq-Comparison 979 995	At least 2 weeks
T86	Eq-Operator 979 987	At least
T87	Procedure 1010 1030	anticancer treatment
T88	Procedure-Name 1010 1030	anticancer treatment
T89	Study 1094 1099	study
T90	Drug 1100 1104	drug
T91	Drug-Name 1100 1104	drug
T92	Eq-Comparison 1080 1085	first
T93	Eq-Temporal-Recency 1080 1085	first
T17	Observation 1110 1120	toxicities
T95	Observation-Name 1110 1120	toxicities
T96	Eq-Comparison 1138 1172	Grade less than or equal to (<=) 1
T97	Eq-Unit 1138 1143	Grade
T98	Eq-Operator 1144 1162	less than or equal
T99	Study 1176 1184	baseline
T101	Procedure 1196 1205	treatment
T102	Drug 1211 1245	prostate-specific membrane antigen
T103	Drug-Name 1211 1245	prostate-specific membrane antigen
T104	Drug 1247 1251	PSMA
T105	Drug-Name 1247 1251	PSMA
T13	Immunization 1281 1302	PSMA-targeted vaccine
T14	Immunization-Name 1281 1302	PSMA-targeted vaccine
T106	Exception 1270 1276	except
T107	Modifier 1336 1347	bone marrow
T108	Modifier 1321 1332	Solid organ
T110	Condition 1386 1395	condition
T111	Condition 1369 1376	Seizure
T112	Condition-Name 1369 1376	Seizure
T114	Condition 1419 1426	seizure
T115	Condition-Name 1419 1426	seizure
T116	Condition 1430 1449	intracranial masses
T117	Condition-Name 1430 1449	intracranial masses
T119	Assertion 1401 1404	may
T120	Condition 1468 1478	malignancy
T121	Condition-Name 1468 1478	malignancy
T122	Other 1455 1460	Other
T123	Procedure 1498 1507	treatment
T124	Modifier 1489 1497	systemic
T125	Assertion 1479 1488	requiring
T39	Eq-Value 1510 1512	12
T126	Study 1529 1539	enrollment
A2	Eq-Operator-Value T18 LTEQ
A3	Eq-Operator-Value T19 LTEQ
A4	Eq-Temporal-Unit-Value T20 week
A5	Eq-Temporal-Unit-Value T21 month
A6	Eq-Temporal-Period-Value T31 present
A7	Eq-Temporal-Period-Value T33 past
A8	Eq-Temporal-Period-Value T35 past
A9	Eq-Temporal-Period-Value T37 past
A11	Eq-Operator-Value T72 GTEQ
A12	Assertion-Type-Value E41 hypothetical
A13	Assertion-Type-Value E45 hypothetical
A14	Eq-Operator-Value T86 GTEQ
A15	Eq-Temporal-Recency-Value T93 first-time
A1	Eq-Operator-Value T98 LTEQ
A17	Assertion-Type-Value E72 hypothetical
A18	Assertion-Type-Value E77 hypothetical
R1	Abbrev-Of Arg1:E6 Arg2:E2
R2	Found-By Arg1:E8 Arg2:E10
R3	Found-By Arg1:E26 Arg2:E28
R4	Abbrev-Of Arg1:E30 Arg2:E26
R5	Example-Of Arg1:E37 Arg2:E3
R6	Found-By Arg1:E11 Arg2:E7
R7	Treatment-For Arg1:E40 Arg2:E11
R8	Caused-By Arg1:E47 Arg2:E46
R9	Example-Of Arg1:E15 Arg2:E50
R10	Using Arg1:E59 Arg2:E60
R11	Abbrev-Of Arg1:E61 Arg2:E60
R12	Caused-By Arg1:E69 Arg2:E66
R13	Treatment-For Arg1:E75 Arg2:E73
R14	And Arg1:E6 Arg2:E10
R15	Or Arg1:E21 Arg2:E22
R16	Or Arg1:E25 Arg2:E26
R17	Or Arg1:E32 Arg2:E31
R18	Or Arg1:E35 Arg2:E34
R19	After Arg1:E50 Arg2:E49
R20	Or Arg1:E56 Arg2:E57
R21	Or Arg1:E64 Arg2:E63
R22	Or Arg1:E67 Arg2:E66
R23	Or Arg1:E69 Arg2:E70
R24	Before Arg1:E20 Arg2:E78
